Klinične študije za BOPC v Indiana
10 študij za BOPC išče udeležence na lokacijah v Indiana.
Mesta v Indiana
Uradno besedilo študije (angleško)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Valparaiso
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research-Indianapolis, Indianapolis
Vključevanje udeležencevFaza 2
Starost 40–85 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
Vključevanje udeležencevFaza 2
Starost 40–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Indy Clinical Research- Site Number : 8400071, Indianapolis
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evansville
- Research Site, Indianapolis
- Research Site, Indianapolis
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Munster
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
Vključevanje udeležencevOpazovalna študija
Starost 40 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- ASHA Clinical Research - Munster, LLC, Hammond
- Methodist Hospital Southlake, Merrillville
Vključevanje udeležencevFaza 2/3
Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694Acoustic Waveform Respiratory Evaluation
- Indiana University, Indianapolis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 8–70 · Vsi spoli · Posodobljeno 24. okt. 2025 · NCT06512064Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.